Chartered Trade Mark Attorney, Alexandra Nott explores some of the reasons that trade mark protection remains crucial in today’s business environment.
READ MORE
In this insight, Biotechnology partner Kit Wilkins reviews the US Supreme Court’s decision to Consider “Skinny Labels” in Generic Drug Patent Dispute. The decision could result in significant implications of generic medicines in the US.
READ MORE
In this insight, Holly Rocliffe from Dehns Biotechnology group explores the recently handed down decision in Otsuka Pharmaceutical Co Ltd v Sun Pharma ANZ Pty Ltd [2025] FCAFC 161[1], in which the Full Court of the Federal Court of Australia (Full Court) has ruled that patent term extension (PTE) is only available for patents which claim an active pharmaceutical ingredient (API).
READ MORE
The first decision from the UPC on sufficiency — handed down in the Amgen v. Sanofi case — provides the first clear guidance on how the court will address whether a patent’s disclosure is sufficient.
READ MORE
In this insight, Dehns Partner Rob Jackson and Conor Wilman from our Technology, Software and Engineering group explore the UPC’s Court of Appeal recent issues of two important decisions about how it will assess inventive step in patent cases.
READ MORE
In a very recent development that will come as a relief to businesses, the UK Government has issued some guidance on what will happen to EU intellectual property rights in the event the UK and EU fail to reach an agreement by 29 March 2019 (a “no deal” scenario).
“We live in interesting times” – this is what we were told by Torbjorn Roe Isaksen (the Norwegian Minister of Trade and Industry) at the Cutting Edge festival in Oslo this week. I tend to agree and it is not the curse it once was. As we watched Cellink print a 3D ear during Itedale Namro Redwan’s short presentation and listened to Thomas Anglero (IBM) explain why the current generation are always on their phones (and making millions while seemingly taking endless selfies) it is difficult to argue that these aren’t interesting times.
The government has recently issued a notice outlining the effect on the UK patent system were the UK to leave the EU without an agreement (a “no deal” scenario) in March 2019.
In what is being claimed as a world first, the first patent applications for technologies that have been developed on the International Space Station (ISS) have been filed.
UK drinks producer and distributor, Copestick Murray Limited, has recently received mixed results from the UKIPO in connection with its trade mark SILENT PEAK, ultimately resulting in the mark being refused registration.
Dolce & Gabbana and “paper aprons“. No, I’m not referring to the fashion house’s autumn/winter 2018 collection.
The well-known luxury brand recently succeeded in a trade mark opposition before the UK Intellectual Property Office (UK IPO), against a company interested in paper clothing.
A recent court case in China has clarified the scope of protection afforded by registered designs for graphical user interfaces (GUIs).
A recent landmark decision of the Court of Justice of the European Union (CJEU) on the use of gene editing technologies to create new crops and livestock animals has sided with environmentalists and food safety groups, prompting outcry from the biotech industry.
Subscribe here for updates on IP news, events and webinars.
|